Immune checkpoint signaling and cancer immunotherapy
Abstract Immune checkpoint blockade therapy has become a major weapon in fighting cancer. Antibody drugs, such as anti-PD-1 and anti-PD-L1, demonstrate obvious advantages such as broad applicability across cancer types and durable clinical response when treatment is effective. However, the overall r...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Revisão |
| Jazyk: | angličtina |
| Vydáno: |
2020
|
| On-line přístup: | https://doi.org/10.1038/s41422-020-0343-4 https://www.nature.com/articles/s41422-020-0343-4.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|